Related Experiment Videos
Regulatory mechanisms of replication growth limits in cellular senescence
1Institute of Biochemistry, National Taiwan University, College of Medicine, Taipei, ROC.
Abstract:
Normal human diploid fibroblasts cannot divide indefinitely in culture. At the end of their lifespan they withdraw from the cell cycle permanently by a process termed cellular senescence. Recent molecular studies indicate that upregulation of two inhibitors of cyclin-dependent kinases, p16 and p21, is responsible for blocking the G1/S transition in senescent cells. Although the state of senescence resembles terminal differentiation in that both exhibit irreversible growth arrest and resistance to apoptosis, other molecular changes are seen only in senescent cells. This suggests that the signal pathway specific for senescence is present in normal cells. Changes in chromosomes, such as progressive shortening of the telomeres and erosive damage by detrimental by-products in metabolism, may be the signals that trigger senescence, leading to the inactivation of cell cycle progression. On the other hand, it seems that a dominant genetic program is intrinsically preset to ensure a growth limit in the normal cell. This notion is supported by cell fusion and microcell transfer experiments which show that escaping from senescence requires recessive mutations in senescence-specific genes. Identification of these participating genes and clarification of their mode of action will provide the basis for understanding the mechanisms governing the differences between mortality in normal cells and immortality in cancer cells.
Insights
Cellular senescence permanently halts normal cell division, driven by cell cycle inhibitors p16 and p21. Escaping this programmed aging requires specific gene mutations, offering insights into cancer cell immortality.
Area of Science:
- Cell Biology
- Molecular Biology
- Genetics
Background:
- Normal human diploid fibroblasts have a finite lifespan and undergo permanent cell cycle withdrawal, a process known as cellular senescence.
- Cellular senescence shares characteristics with terminal differentiation, including irreversible growth arrest and apoptosis resistance, but involves distinct molecular changes.
- The precise molecular pathways and genetic underpinnings of senescence in normal cells remain incompletely understood.
Purpose of the Study:
- To elucidate the molecular mechanisms driving cellular senescence in normal human fibroblasts.
- To investigate the role of cyclin-dependent kinase inhibitors (p16 and p21) in cell cycle arrest during senescence.
- To explore the genetic basis for escaping senescence and its implications for cellular immortality.
Main Methods:
- Analysis of cyclin-dependent kinase inhibitors (p16 and p21) in senescent cells.
- Investigation of chromosomal changes, including telomere shortening and metabolic damage, as potential senescence triggers.
- Utilizing cell fusion and microcell transfer experiments to study senescence escape mechanisms.
Main Results:
- Upregulation of p16 and p21 was identified as a key factor in blocking the G1/S cell cycle transition in senescent cells.
- Chromosomal alterations like telomere shortening and metabolic damage are implicated as senescence-inducing signals.
- Cell fusion and microcell transfer experiments suggest that overcoming senescence necessitates recessive mutations in specific senescence-related genes.
Conclusions:
- Cellular senescence is a programmed process in normal cells, involving specific molecular pathways and genetic control.
- Understanding senescence genes and their functions is crucial for differentiating normal cell mortality from cancer cell immortality.
- Further research into senescence mechanisms could reveal novel therapeutic targets for age-related diseases and cancer.